Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras-Reference-Cited by-同舟云学术

Dyrk2 gene transfer suppresses hepatocarcinogenesis by promoting the degradation of Myc and Hras

Published:2023-07 Issue:7 Volume:5 Page:100759
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Kamioka Hiroshi,Yogosawa Satomi^ORCID,Oikawa Tsunekazu^ORCID,Aizawa Daisuke,Ueda Kaoru,Saeki Chisato,Haruki Koichiro^ORCID,Shimoda Masayuki,Ikegami Toru,Nishikawa Yuji^ORCID,Saruta Masayuki^ORCID,Yoshida Kiyotsugu^ORCID

Funder

Japan Society for the Promotion of Science

Jikei University School of Medicine

Bristol-Myers Squibb Foundation

Japan Society for the Promotion of Science London

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference50 articles.

1. Hepatocellular carcinoma;El-Serag;N Engl J Med,2011

2. AASLD guidelines for the treatment of hepatocellular carcinoma;Heimbach;Hepatology,2018

3. EASL clinical Practice guidelines: management of hepatocellular carcinoma;J Hepatol,2018

4. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma;Finn;N Engl J Med,2020

5. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HRAS Induces Ferroptosis through Upregulating HSPB1 in Hepatocellular Carcinoma;Combinatorial Chemistry & High Throughput Screening;2024-07-22

2. Aberrant differentiation and proliferation of hepatocytes in chronic liver injury and liver tumors;Pathology International;2024-06-05

3. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-06

4. Functional Roles of DYRK2 as a Tumor Regulator;Current Issues in Molecular Biology;2023-10-23